BioSpace: Lantern Pharma Expands into Additional Pediatric Cancers Through a Collaboration with The Greehey Children’s Cancer Research Institute (GCCRI) at University of Texas Health Science Center-San Antonio (Houghton)
February 16, 2022
Published: Feb 15, 2022 Original Publication: BioSpace - Lantern Pharma's A.I. and machine learning platform, RADR®, aided in the identification of additional pediatric cancers where Lantern's portfolio of drug candidates can be leveraged. - The research will initially focus on advancing the development of Lantern Pharma's drug candidate, LP-184, into additional childhood [...]
